Dow Down 0.13% Nasdaq Up 0.05%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
5.78 Up 0.50(9.37%) 9:32AM EDT - Nasdaq Real Time Price
Prev Close:5.28
Open:N/A
Bid:5.86 x 200
Ask:5.88 x 700
1y Target Est:8.72
Beta:1.51
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.75 - 5.85
52wk Range:2.15 - 19.18
Volume:1,496,204
Avg Vol (3m):7,198,700
Market Cap:1.08B
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIAUp 9.37%1.08B
NVSUp 0.71%227.77B
PFEUp 0.33%185.45B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback